The Intravenous Immunoglobulin (IVIG) market across the 7MM was valued at around USD 7,384 million in 2025 and is expected to ...

Of all the autoimmune diseases out there, Guillain-Barre syndrome is definitely one of the less common. This condition, which ...

Argenx (ARGX) announced an update on their ongoing clinical study. Argenx is currently recruiting participants for a study titled ‘Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study’.

Jillian Kubala, MS, is a registered dietitian based in Westhampton, NY. Jillian uses a unique and personalized approach to help her clients achieve optimal wellness through nutrition and lifestyle ...